Michael W. Bonney - 02 Aug 2021 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role: Executive Chair, Director
Signature: By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Michael W. Bonney
Issuer symbol: ALNY
Transactions as of: 02 Aug 2021
Net transactions value: $0
Form type: 4
Filing time: 03 Aug 2021, 19:31:30 UTC
Previous filing: 19 Jul 2021
Next filing: 19 May 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALNY	Restricted Stock Units	Award	$0	+22,477		$0.000000	22,477	02 Aug 2021	Common Stock	22,477		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.
F2	The restricted stock units vest in full on the earlier of August 2, 2023 and the date the Reporting Person ceases to serve as a director of the Company other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors.